March 3rd, 2026: Federal Judge Appoints Leadership for GLP1 Vision Loss Lawsuits Multiple lawsuits alleging vision loss from GLP1 drugs, including Ozempic, Wegovy, and Mounjaro have been consolidated into a multidistrict litigation in the Eastern District of Pennsylvania, the same court responsible for handling GLP-1 lawsuits involving gastrointestinal injuries
These events were generally mild to moderate , occurred predominantly during dose escalation, and often decreased in frequency or intensity as participants adapted to the target dose
Tirzepatide, a Dual GIP/GLP-1 Receptor Co-Agonist for the Treatment of Type 2 Diabetes with Unmatched Effectiveness Regrading Glycaemic Control and Body Weight Reduction. Cardiovascular Diabetology , vol
Tips For Managing Sulfur Burps On Ozempic 1
Preprint at bioRxiv (2020)
the level of CRP is related to the weight loss percentage treated with BN